• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

确立专业地位:作为体现健康运动组织的加拿大社区医用大麻药房

Establishing expertise: Canadian community-based medical cannabis dispensaries as embodied health movement organisations.

作者信息

Penn Rebecca A

机构信息

Dalla Lana School of Public Health, University of Toronto, 6th Floor, 155 College Street, Toronto, ON M5T 3M7, Canada.

出版信息

Int J Drug Policy. 2014 May;25(3):372-7. doi: 10.1016/j.drugpo.2013.12.003. Epub 2013 Dec 17.

DOI:10.1016/j.drugpo.2013.12.003
PMID:24439711
Abstract

In this commentary, I describe how, through both advocacy and the generation of new knowledge, community-based medical cannabis dispensaries have contributed to the broader dialogue regarding the legal and safe provision of medical cannabis in Canada. By employing an embodied health movement framework (Brown et al., 2004), this analysis highlights the role of dispensaries in creating new knowledge, challenging existing practices, and advancing their agenda to legitimise cannabis as a therapeutic substance and offer an alternative model for its provision. Although the community-based, holistic approach that dispensaries offer has not been adopted by the Canadian government, dispensaries have achieved success in being recognized as credible stakeholders and experts in the ongoing debate on the legal provision of medical cannabis in Canada.

摘要

在这篇评论中,我描述了基于社区的医用大麻药房如何通过宣传和新知识的产生,为加拿大关于合法且安全地提供医用大麻的更广泛对话做出贡献。通过运用一种体现健康运动的框架(布朗等人,2004年),本分析突出了药房在创造新知识、挑战现有做法以及推进其将大麻合法化作为一种治疗物质并提供替代供应模式的议程方面所发挥的作用。尽管加拿大政府尚未采纳药房所提供的基于社区的整体方法,但药房在加拿大医用大麻合法供应的持续辩论中已成功被视为可信的利益相关者和专家。

相似文献

1
Establishing expertise: Canadian community-based medical cannabis dispensaries as embodied health movement organisations.确立专业地位:作为体现健康运动组织的加拿大社区医用大麻药房
Int J Drug Policy. 2014 May;25(3):372-7. doi: 10.1016/j.drugpo.2013.12.003. Epub 2013 Dec 17.
2
Moral regulation and the presumption of guilt in Health Canada's medical cannabis policy and practice.加拿大卫生部医用大麻政策与实践中的道德规范及有罪推定
Int J Drug Policy. 2009 Jul;20(4):296-303. doi: 10.1016/j.drugpo.2008.09.007. Epub 2009 Jan 4.
3
Are dispensaries indispensable? Patient experiences of access to cannabis from medical cannabis dispensaries in Canada. dispensaries 是否不可或缺?加拿大从医用大麻药房获取大麻的患者体验。
Int J Drug Policy. 2017 Sep;47:1-8. doi: 10.1016/j.drugpo.2017.05.046. Epub 2017 Jun 28.
4
Cannabis for therapeutic purposes: patient characteristics, access, and reasons for use.医用大麻:患者特征、获取途径和使用原因。
Int J Drug Policy. 2013 Nov;24(6):511-6. doi: 10.1016/j.drugpo.2013.08.010. Epub 2013 Sep 9.
5
Are Canadian Cannabis Dispensaries Counselling Pregnant Women Appropriately?加拿大的大麻药房是否恰当地为孕妇提供咨询服务?
J Obstet Gynaecol Can. 2021 Apr;43(4):506-510.e2. doi: 10.1016/j.jogc.2020.08.011. Epub 2020 Aug 25.
6
Barriers to access for Canadians who use cannabis for therapeutic purposes.为治疗目的使用大麻的加拿大人面临的准入障碍。
Int J Drug Policy. 2014 Jul;25(4):691-9. doi: 10.1016/j.drugpo.2014.02.009. Epub 2014 Feb 28.
7
Dermatology-Related Uses of Medical Cannabis Promoted by Dispensaries in Canada, Europe, and the United States.加拿大、欧洲和美国药房所推广的医用大麻在皮肤科方面的用途。
J Cutan Med Surg. 2019 Mar/Apr;23(2):178-184. doi: 10.1177/1203475418808761. Epub 2018 Oct 31.
8
Geolocation of Maryland Medical Marijuana Dispensaries by Community Income and Racial Characteristics: An Ecological Design.马里兰州医疗大麻药房的地理位置与社区收入和种族特征:生态设计。
Subst Use Misuse. 2021;56(2):318-326. doi: 10.1080/10826084.2020.1868516. Epub 2021 Jan 10.
9
Association of State Policies Allowing Medical Cannabis for Opioid Use Disorder With Dispensary Marketing for This Indication.州政策允许将医用大麻用于阿片类药物使用障碍与该适应症的药房营销之间的关联。
JAMA Netw Open. 2020 Jul 1;3(7):e2010001. doi: 10.1001/jamanetworkopen.2020.10001.
10
Regulating compassion: an overview of Canada's federal medical cannabis policy and practice.规范同情心:加拿大联邦医用大麻政策与实践概述。
Harm Reduct J. 2008 Jan 28;5:5. doi: 10.1186/1477-7517-5-5.

引用本文的文献

1
A paradigm shift towards production of sustainable bioenergy and advanced products from /hemp biomass in Canada.加拿大从大麻生物质生产可持续生物能源和先进产品的范式转变。
Biomass Convers Biorefin. 2022 Mar 19:1-22. doi: 10.1007/s13399-022-02570-6.
2
The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications.大麻在澳大利亚医疗保健领域走向主流的历程:专业医学出版物中的表述
J Cannabis Res. 2021 Nov 21;3(1):48. doi: 10.1186/s42238-021-00105-w.
3
A qualitative review of cannabis stigmas at the twilight of prohibition.
对大麻污名在禁令末期的定性综述。
J Cannabis Res. 2020 Dec 7;2(1):46. doi: 10.1186/s42238-020-00056-8.
4
Autonomous Health Movements: Criminalization, De-Medicalization, and Community-Based Direct Action.自主健康运动:刑事定罪、非医学化与基于社区的直接行动
Health Hum Rights. 2020 Dec;22(2):85-97.
5
Developing expertise, customising sleep, enhancing study practices: exploring the legitimisation of modafinil use within the accounts of UK undergraduate students.培养专业技能、定制睡眠、改进学习方法:在英国本科生的叙述中探讨莫达非尼使用的合法化问题。
Drugs (Abingdon Engl). 2019 Jan 16;26(4):347-355. doi: 10.1080/09687637.2018.1555231. eCollection 2019.